Report #2857406

Received Sep 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NC
Recovered: Unknown
Vaccinated: Aug 18, 2025
Onset: Aug 1, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	—

Symptoms (1)

Herpes zoster

Symptom narrative

Shingles case after 1st dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 18-AUG-2025, the patient received the 1st dose of Shingrix. In AUG-2025, less than 2 weeks after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles case after 1st dose). The outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 29-AUG-2025 The reporter reported that the patient was vaccinated on 18th August 2025 and was here today (on the reporting day) with shingles. The reporter asked can a patient get shingles from vaccine.